title: Comment on: Steroid-resistant kaposiform hemangioendothelioma: A retrospective study of 37 patients treated with vincristine and long-term follow-up.
authors.affiliation: Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
authors.forename: Denise M
authors.initials: DM
authors.lastname: Adams
authors.affiliation: Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
authors.forename: Adrienne M
authors.initials: AM
authors.lastname: Hammill
authors.affiliation: Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
authors.forename: Paula S
authors.initials: PS
authors.lastname: Mobberley-Schuman
authors.affiliation: Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Cameron C
authors.initials: CC
authors.lastname: Trenor
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D005260:Female; D006390:Hemangioendothelioma / Q000188:drug therapy*; D006801:Humans; D059885:Kasabach-Merritt Syndrome / Q000188:drug therapy*; D008297:Male; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D013256:Steroids / Q000008:administration & dosage*; D014750:Vincristine / Q000008:administration & dosage*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D013256:Steroids; D014750:Vincristine